A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that ...
Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, has sponsored PanCAN PurpleStride for ...
ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the launch of its enhanced Avantect(R) Pancreatic Cancer Test, which delivers ...
A Lafayette father's battle with stage 4 pancreatic cancer is taking a hopeful turn as he becomes the first in Colorado to ...
The ongoing Phase 2 DURIPANC clinical trial of Ampligen and AstraZeneca’s durvalumab in the treatment of late-stage pancreatic cancer is producing promising results. Based on the success so far, as ...
TOKYO--(BUSINESS WIRE)--HIROTSU BIO SCIENCE INC. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu; hereafter referred to as "HIROTSU") is pleased to announce the commercialization of ...
Welltica+ on MSN
New research: Nerves may trigger pancreatic cancer
New research suggests that the body’s own nerves may help initiate the disease earlier than previously believed.
Namodenoson is a highly selective A3 adenosine receptor (A3AR) agonist, which has shown a compelling safety profile and demonstrated anti-tumor activity in preclinical pancreatic cancer models. The ...
Namodenoson (CF102) demonstrated a favorable safety profile in patients with advanced pancreatic ductal adenocarcinoma (PDAC) ...
More than 17,000 individuals with cancer died from their malignancy within a year of their diagnosis during the COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results